n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Bone Loss, Osteoclastic in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, SW | 1 |
| Chambers, TJ | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis.
Topics: Amidines; Animals; Benzylamines; Biomarkers; Bone and Bones; Bone Resorption; Carrier Proteins; Catt | 2000 |